ANIX

Anixa Biosciences, Inc.

3.50 USD
-0.01 (-0.28%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Anixa Biosciences, Inc. stock is down -23.91% since 30 days ago. The next earnings date is Mar 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 March’s closed higher than February. 100% of analysts rate it a buy.

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is also developing immuno-therapy drugs against cancer.